Risk Stratification for Noncardiac Surgery
In their discussion of a new preoperative testing modality, Massie and Manganol conclude that risk assessment should not routinely include supplemental cardiovascular testing to confirm the presence of ischemic heart disease. They argue that the decision to use a test should be based primarily on the clinical evaluation. Once the probability of coronary artery disease is determined on the basis of the history, physical examination, and core laboratory data, we believe that weight should be given to the proposed surgery as the initial point in the preoperative evaluation.
We have recently proposed an alternative strategy, in which the starting point of the clinical evaluation begins with (1) In conclusion, we agree with the authors of the editorial that clinical evaluation is important in determining which patients might benefit from preoperative testing. However, we believe that the surgical procedure should be included as a starting point in the decision process.
